These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
353 related items for PubMed ID: 11083321
1. Clinical characteristics and prognosis of myasthenia gravis in older people. Evoli A, Batocchi AP, Minisci C, Di Schino C, Tonali P. J Am Geriatr Soc; 2000 Nov; 48(11):1442-8. PubMed ID: 11083321 [Abstract] [Full Text] [Related]
2. Development of generalized disease at 2 years in patients with ocular myasthenia gravis. Kupersmith MJ, Latkany R, Homel P. Arch Neurol; 2003 Feb; 60(2):243-8. PubMed ID: 12580710 [Abstract] [Full Text] [Related]
5. Randomized trial of azathioprine or prednisone for initial immunosuppressive treatment of myasthenia gravis. Bromberg MB, Wald JJ, Forshew DA, Feldman EL, Albers JW. J Neurol Sci; 1997 Sep 01; 150(1):59-62. PubMed ID: 9260858 [Abstract] [Full Text] [Related]
6. Myasthenia gravis in children: a longitudinal study. Ashraf VV, Taly AB, Veerendrakumar M, Rao S. Acta Neurol Scand; 2006 Aug 01; 114(2):119-23. PubMed ID: 16867035 [Abstract] [Full Text] [Related]
7. Long-term prednisone followed by thymectomy in myasthenia gravis. Mann JD, Johns TR, Campa JF, Muller WH. Ann N Y Acad Sci; 1976 Aug 01; 274():608-22. PubMed ID: 1066998 [Abstract] [Full Text] [Related]
8. Factors influencing the relapse risk at steroid dose reduction in myasthenia gravis. Scherpbier HJ, Oosterhuis HJ. Clin Neurol Neurosurg; 1987 Aug 01; 89(3):145-50. PubMed ID: 3665287 [Abstract] [Full Text] [Related]
9. Ocular myasthenia gravis: response to long-term immunosuppressive treatment. Sommer N, Sigg B, Melms A, Weller M, Schepelmann K, Herzau V, Dichgans J. J Neurol Neurosurg Psychiatry; 1997 Feb 01; 62(2):156-62. PubMed ID: 9048716 [Abstract] [Full Text] [Related]
10. Immunosuppressive treatment for juvenile myasthenia gravis. Badurska B, Ryniewicz B, Strugalska H. Eur J Pediatr; 1992 Mar 01; 151(3):215-7. PubMed ID: 1601015 [Abstract] [Full Text] [Related]
11. Plasmaexchange in the treatment of myasthenia gravis associated with thymoma. Gogovska L, Ljapcev R, Polenakovic M, Stojkovski L, Popovska M, Grcevska L. Int J Artif Organs; 2003 Feb 01; 26(2):170-3. PubMed ID: 12653352 [Abstract] [Full Text] [Related]
12. Outcome in juvenile-onset myasthenia gravis: a retrospective study with long-term follow-up of 79 patients. Lindner A, Schalke B, Toyka KV. J Neurol; 1997 Aug 01; 244(8):515-20. PubMed ID: 9309559 [Abstract] [Full Text] [Related]
17. The effect of prednisone on the progression from ocular to generalized myasthenia gravis. Monsul NT, Patwa HS, Knorr AM, Lesser RL, Goldstein JM. J Neurol Sci; 2004 Feb 15; 217(2):131-3. PubMed ID: 14706214 [Abstract] [Full Text] [Related]
18. [Ocular myasthenia: clinical course and strategies for treatment]. Marzo ME, Pérez López-Fraile I, Capablo JL, Ara JR, Usón M. Rev Neurol; 1998 Mar 15; 26(151):398-400. PubMed ID: 9585951 [Abstract] [Full Text] [Related]
19. [Thymectomy and immunosuppression in myasthenia gravis: a prospective study]. Sandmann MC, Gorz AM, Gracia CM, Batista RJ, Seixas RR, Bittencourt PR. Arq Neuropsiquiatr; 1990 Mar 15; 48(1):44-8. PubMed ID: 2378574 [Abstract] [Full Text] [Related]
20. Experience with starting tacrolimus postoperatively after transsternal extended thymectomy in patients with myasthenia gravis. Ponseti JM, Azem J, Fort JM, López-Cano M, Vilallonga R, Gamez J, Armengol M. Curr Med Res Opin; 2006 May 15; 22(5):885-95. PubMed ID: 16709310 [Abstract] [Full Text] [Related] Page: [Next] [New Search]